Publication
Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting
Caterina Breitenstein, Tanja Grewe, Agnes Flöel, Wolfram Ziegler, Luise Springer, Peter Martus, Walter Huber, Klaus Willmes, E Bernd Ringelstein, Karl Georg Haeusler, Stefanie Abel, Ralf Glindemann, Frank Domahs, Frank Regenbrecht, Klaus-Jürgen Schlenck, Marion Thomas, Hellmuth Obrig, Ernst de Langen, Roman Rocker, Franziska Wigbers, Christina Rühmkorf, Indra Hempen, Jonathan List, Annette Baumgaertner, A Villringer, M Bley, M Jöbges, K Halm, J Schulz, C Werner, G Goldenberg, G Klingenberg, E König, F Müller, B Gröne, S Knecht, R Baake, J Knauss, S Miethe, U Steller, R Sudhoff, E Schillikowski, G Pfeiffer, K Billo, H Hoffmann, F-J Ferneding, S Runge, T Keck, V Middeldorf, S Krüger, B Wilde, K Krakow, C Berghoff, F Reinhuber, I Maser, W Hofmann, C Sous-Kulke, W Schupp, A Oertel, D Bätz, F Hamzei, K Schulz, A Meyer, A Kartmann, O'N Som, S-B Schipke, S Bamborschke
The Lancet, April 2017, Elsevier
DOI: 10.1016/s0140-6736(17)30067-3